Intellectual Dishonesty AND Possible Inebriation ALL in ONE!!!

[Guest guest]

Guys (and Gals) check out this study and note that the alleged

intelligent folk at the Washington Post along with many other

alleged intelligent media outlets felt this study worthy of

publishing.

Note:

MASSIVE subject population of a whopping 47.

Also note the response to this quote as it demonstrates how truly

CLUELESS the medical profession is regarding heart disease

treatment...

" ...4 percent reduction in the plaque lining their arteries, a

reduction 10 times greater than anything scientists had tried

previously, the researchers found. " When the statisticians delivered

the data to me, I fell off my chair, " Nissen said. "

This quote was obviously taken out of context in that Nissen was

referring to the effects of his Liquid Lunch that had him falling

off his chair.

I'm no statistician but last math class I took they said that 10

times less than 4% ain't much.

These guys are " falling " off chairs based on a 47 subject, 6 week

study, that shows 4% improvement (10x's what they've done before?)

can you say DESPERATE!?

Synthetic 'good cholesterol' reduces plaque in arteries

By Rob Stein

The Washington Post

A synthetic form of " good cholesterol " has been shown to quickly

shrink blockages clogging coronary arteries, offering for the first

time the possibility of a drug that could actually rapidly reverse

heart disease, researchers reported Tuesday.

In a small, preliminary study, the laboratory-made substance,

which mimics a type of cholesterol discovered in a group of

surprisingly healthy villagers in rural Italy, significantly reduced

in just six weeks the amount of plaque narrowing arteries of heart-

attack and chest-pain patients, the researchers reported.

Because the approach attacks the underlying source of many heart

attacks, the results could mark a milestone in the search for new

ways to treat the nation's No. 1 killer, researchers said.

" For the first time, we've shown that you can reverse coronary

disease with drug therapy in a matter of weeks, " said Nissen,

a cardiologist at the Cleveland Clinic who coordinated the

nationwide study. " We really have, for the first time, the

opportunity to attack this disease at its fundamental basis. It's a

paradigm shift. "

Nissen and other researchers cautioned that the study only

involved 47 patients, and further studies are needed to confirm the

findings, fully evaluate the drug's safety and determine whether the

treatment actually cuts the risk of heart attacks and strokes.

" It's extremely preliminary, " said , clinical

director of the Washington University Hospital Women's Heart

Program, speaking on behalf of the American Heart Association. " But

it is very intriguing. "

Regardless of whether this particular drug eventually offers a

practical, effective treatment, other experts said the study has

opened up an new way to approach treating atherosclerosis, known

commonly as hardening of the arteries.

Scientists have long known that there are two forms of

cholesterol: One is low-density lipoprotein (LDL), which is the " bad

cholesterol " because it accumulates inside artery walls, causing the

vessels to narrow and setting the stage for heart attacks and

strokes. The other is high-density lipoprotein (HDL), called

the " good cholesterol " because it protects against heart disease,

primarily by lowering LDL levels.

About 30 years ago, researchers discovered a group of about 40

people living in the small rural northern Italian town of Limone Sul

Garda who had a surprisingly low rate of heart disease despite their

extremely low HDL levels. Scientists determined that their HDL was

slightly unusual, raising the possibility that it provided unusually

powerful protection against heart disease.

Esperion Therapeutics Inc. of Ann Arbor, Mich., developed a

genetically engineered form of this version of HDL, dubbed ApoA-I

Milano, and showed that it reduced plaque inside the arteries of

laboratory animals. The company then asked Nissen to test it in

people.

In the study, Nissen and colleagues at 10 centers around the

country gave weekly infusions of either the synthetic HDL or an

inert placebo to 47 heart disease patients for five weeks. The

plaque clogging the walls of their arteries were carefully measured

before and after the treatment using an extremely precise ultrasound

technique.

Compared with those who received the placebo, the patients who

received the synthetic HDL experienced about a 4 percent reduction

in the plaque lining their arteries, a reduction 10 times greater

than anything scientists had tried previously, the researchers

found. " When the statisticians delivered the data to me, I fell off

my chair, " Nissen said.

[Guest guest]

< " ...4 percent reduction in the plaque lining their arteries, a

reduction 10 times greater than anything scientists had tried

previously, the researchers found. " When the statisticians delivered

the data to me, I fell off my chair, " Nissen said. " >

This was on NBC news or something like that last night too. I remember

seeing it as I was passing through the living room and just chuckled to

myself as well. My hubby and I both work for the dreaded health insurance

company so are quite used to the constant influx of new drugs (and their

high costs)....so we both rolled our eyes and opted for a comedy channel

that was actually intended to be funny. Sigh. What next. Do you want to

know the drug almost always in the top 3 filled for my companies? Lipitor

of course.

_________________________________________________________________

MSN Messenger with backgrounds, emoticons and more.

http://www.msnmessenger-download.com/tracking/cdp_customize

[Guest guest]

Another you have to pay me from the cradle to the grave pitch. Or as a song

daughter listens to says from the pampers to the depends. Oh, no we

couldn't possibly say " eat cholesterol " Interesting how miracle cures seem

to always be found elsewhere.

Wanita